onr:"swepub:oai:DiVA.org:umu-129121"
Search: onr:"swepub:oai:DiVA.org:umu-129121" > Ion pumps as biolog...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Aureliano, Manuel (author)
Ion pumps as biological targets for decavanadate
- Article/chapterEnglish2013
Publisher, publication year, extent ...
- Royal Society of Chemistry (RSC),2013
- printrdacarrier
Numbers
- LIBRIS-ID:oai:DiVA.org:umu-129121
- https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-129121URI
- https://doi.org/10.1039/c3dt50462jDOI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- The putative applications of poly-, oligo-and mono-oxometalates in biochemistry, biology, pharmacology and medicine are rapidly attracting interest. In particular, these compounds may act as potent ion pump inhibitors and have the potential to play a role in the treatment of e. g. ulcers, cancer and ischemic heart disease. However, the mechanism of action is not completely understood in most cases, and even remains largely unknown in other cases. In the present review we discuss the most recent insights into the interaction between mono-and polyoxometalate ions with ion pumps, with particular focus on the interaction of decavanadate with Ca2+-ATPase. We also compare the proposed mode of action with those of established ion pump inhibitors which are currently in therapeutic use. Of the 18 classes of compounds which are known to act as ion pump inhibitors, the complete mechanism of inhibition is only known for a handful. It has, however, been established that most ion pump inhibitors bind mainly to the E2 ion pump conformation within the membrane domain from the extracellular side and block the cation release. Polyoxometalates such as decavanadate, in contrast, interact with Ca2+-ATPase near the nucleotide binding site domain or at a pocket involving several cytoplasmic domains, and therefore need to cross through the membrane bilayer. In contrast to monomeric vanadate, which only binds to the E2 conformation, decavanadate binds to all protein conformations, i.e. E1, E1P, E2 and E2P. Moreover, the specific interaction of decavanadate with sarcoplasmic reticulum Ca2+-ATPase has been shown to be non-competitive with respect to ATP and induces protein cysteine oxidation with concomitant vanadium reduction which might explain the high inhibitory capacity of V-10 (IC50 = 15 mu M) which is quite similar to the majority of the established therapeutic drugs.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
- Fraqueza, Gil (author)
- Ohlin, C. Andre (author)
Related titles
- In:Dalton Transactions: Royal Society of Chemistry (RSC)42:33, s. 11770-117771477-92261477-9234
Internet link
Find in a library
- Dalton Transactions (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Aureliano, Manue ...
- Fraqueza, Gil
- Ohlin, C. Andre
- About the subject
-
- NATURAL SCIENCES
- NATURAL SCIENCES
- and Chemical Science ...
- and Inorganic Chemis ...
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Basic Medicine
- and Pharmacology and ...
- Articles in the publication
- Dalton Transacti ...
- By the university
- Umeå University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
